Close Menu

GE Healthcare

The product uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells.

The partners are preparing to release two updates to Navify Tumor Board that support automatic importation of structured Foundation Medicine test reports.

The cancer genetics testing provider acquired its new business unit from GE Healthcare.

By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.

NeoGenomics and GE Healthcare will also collaborate on a bioinformatics initiative for personalized oncology.

The deal gives Axiogenesis access to IP that will allow it to commercialize stem cell-derived assays and disease models for use in drug discovery.

The licenses provide non-exclusive access to the IP for research applications.

General Electric has been awarded

NEW YORK (GenomeWeb) – GE Healthcare today announced a deal between its affiliate Clarient Diagnostic Services and GlaxoSmithKline to create a network of clinical laboratories to identify genetic mutations associated with different tumor types.

Pages

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.